Implementation of a Telemedicine Direct Oral Anticoagulant Monitoring Program at a Safety-Net Hospital. [PDF]
Kaplon SC +4 more
europepmc +1 more source
Dual direct oral anticoagulant therapy in challenging thrombosis: a case series. [PDF]
Chornenki NLJ +4 more
europepmc +1 more source
Importance of blood pressure lowering in patients with direct oral anticoagulant-associated intracerebral haemorrhage in the acute phase and for secondary prevention. [PDF]
Parry-Jones AR +5 more
europepmc +1 more source
The Comparison of Aspirin and Direct Oral Anticoagulant as Thromboprophylaxis Following Total Knee Replacement: A Retrospective Study. [PDF]
Sumargono E +5 more
europepmc +1 more source
Evaluation of direct oral anticoagulant continuation versus switching to a parenteral anticoagulant in critically ill patients: a retrospective cohort study. [PDF]
Alshehri AM +6 more
europepmc +1 more source
Management of direct oral anticoagulant drug interactions in hospitalized patients. [PDF]
Al Zaria MH +4 more
europepmc +1 more source
Related searches:
Non–vitamin K antagonist oral anticoagulants, also known as direct oral anticoagulants, are a relatively recent class of medications introduced into clinical practice. Due to their safety profiles, fixed dosing, and lack of need for frequent laboratory monitoring, they are becoming preferred to traditional anticoagulation with warfarin in many cases of
Michael G Mount, Panna A. Codner
openaire +2 more sources
Measuring Direct Oral Anticoagulants
2017Direct oral anticoagulants (DOACs) can be quantified using methods that can be performed in any clinical or research laboratory using manual or automated instrument platforms. Dabigatran etexilate, the oral direct thrombin inhibitor, can be quantified by drug-calibrated clot or chromogenic-based assays using either thrombin or ecarin as substrates ...
Robert C, Gosselin, Jonathan, Douxfils
openaire +3 more sources
New anticoagulants: Moving beyond the direct oral anticoagulants
Journal of Thrombosis and Haemostasis, 2021Although anticoagulants have been in use for more than 80Â years, heparin and vitamin K antagonists were the sole available options until recently. Although these agents revolutionized the prevention and treatment of thrombotic diseases, their use has been hampered by the necessity for coagulation monitoring and by bleeding complications resulting in ...
James C. Fredenburgh, Jeffrey I. Weitz
openaire +2 more sources
Direct Oral Anticoagulants and Women
Seminars in Thrombosis and Hemostasis, 2016Direct oral anticoagulants (DOACs) provide an effective, safe, and convenient therapeutic alternative to warfarin and other vitamin K antagonists (VKAs), and are now established for a wide range of indications. The use of DOACs in women merits special consideration due to two main situations: first, in relation to fertility, pregnancy, and lactation in
Cohen, Hannah +4 more
openaire +2 more sources

